These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1693716)

  • 21. The safety of felodipine.
    Lorimer AR; Pringle SD
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S85-9. PubMed ID: 1693736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison and interaction of low dose felodipine and enalapril in the treatment of essential hypertension in elderly subjects.
    Morgan TO; Anderson A; Jones E
    Am J Hypertens; 1992 Apr; 5(4 Pt 1):238-43. PubMed ID: 1599636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year study of felodipine or placebo for stage 1 isolated systolic hypertension.
    Black HR; Elliott WJ; Weber MA; Frishman WH; Strom JA; Liebson PR; Hwang CT; Ruff DA; Montoro R; DeQuattro V; Zhang D; Schleman MM; Klibaner MI
    Hypertension; 2001 Nov; 38(5):1118-23. PubMed ID: 11711508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antianginal effect of felodipine.
    Lorimer AR; Macfarlane P; Pringle S; Barbour MP; Fox Y; Lawrie TD
    J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S107. PubMed ID: 1693713
    [No Abstract]   [Full Text] [Related]  

  • 25. Blood pressure reduction and tolerability of felodipine ER in older and younger hypertensive patients. The Felodipine ER in the Elderly versus Young Working Group.
    Fagan TC
    J Am Geriatr Soc; 1997 Jun; 45(6):712-7. PubMed ID: 9180665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG; Leenen FH; Tanner J
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet aggregation and metabolic control are not affected by calcium antagonist treatment in type II diabetes mellitus.
    Klauser R; Speiser P; Gisinger C; Schernthaner G; Prager R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S93-6. PubMed ID: 1695314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How safe is carvedilol in NIDDM patients with hypertension?
    Choudhury D; Misra A
    Natl Med J India; 1998; 11(3):130-1. PubMed ID: 9707705
    [No Abstract]   [Full Text] [Related]  

  • 29. Felodipine can replace minoxidil in the treatment of refractory hypertension.
    MacLeod D; Wathen CG; Tucker L; Forret EA; Hill TW; Muir AL
    J Hypertens Suppl; 1985 Dec; 3(3):S469-70. PubMed ID: 2856769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Once daily felodipine monotherapy in mild to moderate hypertension.
    Kon SP; Tan HW; Chua CT; Ong ML; Kamsiah J; Maheendran KK; Ponniah CA; Tariq AR; Mahendran T
    Med J Malaysia; 1992 Dec; 47(4):290-6. PubMed ID: 1303482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised, double-blind, parallel study of the anti-hypertensive efficacy and safety of losartan potassium compared with felodipine ER in elderly patients with mild to moderate hypertension.
    Chan JC; Critchley JA; Lappe JT; Raskin SJ; Snavely D; Goldberg AI; Sweet CS
    J Hum Hypertens; 1995 Sep; 9(9):765-71. PubMed ID: 8551492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.
    Todd PA; Faulds D
    Drugs; 1992 Aug; 44(2):251-77. PubMed ID: 1382018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic comparisons of enalapril and felodipine and their combination.
    Morgan TO; Anderson A
    Kidney Int Suppl; 1992 May; 36():S78-81. PubMed ID: 1614072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Felodipine ER formulation in the treatment of mild hypertension: efficacy and tolerability vs placebo.
    Bossini A; Di Veroli C; Cavallotti G; Cagli V
    Br J Clin Pharmacol; 1990 Oct; 30(4):567-71. PubMed ID: 2291869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive treatment and CHD in the elderly.
    Fink KS; Ellsworth A
    Am Fam Physician; 1999 Sep; 60(4):1102, 1104, 1107. PubMed ID: 10507742
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension. Danish Multicentre Group.
    Høegholm A; Wiinberg N; Rasmussen E; Nielsen PE
    J Hum Hypertens; 1995 Mar; 9 Suppl 1():S25-8. PubMed ID: 7783110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Office and ambulatory blood pressure: a comparison between amlodipine and felodipine ER. Danish Multicentre Group.
    Høegholm A; Wiinberg N; Rasmussen E; Nielsen PE
    J Hum Hypertens; 1995 Aug; 9(8):611-6. PubMed ID: 8523374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twenty-four-hour blood pressure monitoring during treatment with extended-release felodipine versus slow-release nifedipine: cross-over study.
    Carroll J; Shamiss A; Zevin D; Levi J; Rosenthal T
    J Cardiovasc Pharmacol; 1995 Dec; 26(6):974-7. PubMed ID: 8606536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Felodipine-ER once daily as monotherapy in hypertension.
    Campbell LM; Cowen KJ; Cranfield FR; Goves JR; Jones DF; Lees CT; Richardson PD; Teal JA; Timerick SJ
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):569-73. PubMed ID: 1691385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications associated with End Stage Renal Disease.
    Khan YH; Sarriff A; Adnan AS; Khan AH; Malhi TH; Jummaat F
    J Coll Physicians Surg Pak; 2015 May; 25(5):392. PubMed ID: 26008675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.